ABBVTICKER
Abbvie Inc.
Congress has disclosed 73 buys and 64 sells of ABBV (Abbvie Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
73
Buy
64
Sell
+9
Net
43
Active politicians
Round-trip watch Still on the books
Members who disclosed buying ABBV and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rohit Khanna | 2025-01-22 | $160.23 | $294.89 | +84.0% | in profit |
| Virginia Foxx | 2024-12-06 | $165.29 | $294.89 | +78.4% | in profit |
| Rob Bresnahan | 2025-05-15 | $173.64 | $294.89 | +69.8% | in profit |
| Jared Moskowitz | 2025-04-07 | $176.66 | $294.89 | +66.9% | in profit |
| Marjorie Taylor Greene | 2025-08-04 | $190.09 | $294.89 | +55.1% | in profit |
| Alan Armstrong | 2026-03-27 | $204.95 | $294.89 | +43.9% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
50.4
▲ pricier than
Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$294.89 ÷ $5.85 = 50.4
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
-113.73
≈ in line with
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$294.89 ÷ $-2.59 = -113.73
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
138 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Pete Sessions | House | SELL ◆ insider convergence | Self · ET IRA | 2026-09-14 | 4 days | +0.8% | $15K–$50K 0.9% of NW |
99.0 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2026-05-05 | 28 days | +4.5% | $1K–$15K <0.1% of NW |
1.1 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2026-03-30 | 3 days | -2.0% | $15K–$50K | 22.3 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence | Self | 2026-03-27 | 116 days | +24.2% | $15K–$50K | 99.6 | ↗ eFD |
| Julie Johnson | House | SELL | Joint · Chase Brokerage Account (3935) | 2025-12-18 | 18 days | -1.2% | $1K–$15K <0.1% of NW |
24.5 | ↗ filing |
| Julia Letlow | House | SELL | Self · Merrill Lynch Investment Account #025 | 2025-12-08 | 24 days | +2.4% | $1K–$15K 1.0% of NW |
25.2 | ↗ filing |
| Julie Johnson | House | SELL | Joint · Chase Brokerage Account (3935) | 2025-11-13 | 22 days | -2.7% | $1K–$15K <0.1% of NW |
50.9 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
66.0 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | -4.5% | $1K–$15K 0.1% of NW |
69.2 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | -4.5% | $1K–$15K 0.1% of NW |
65.1 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence | Joint · Chase Brokerage Account (3935) | 2025-08-14 | 19 days | +3.5% | $1K–$15K <0.1% of NW |
66.5 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2025-08-04 | 1 days | +0.7% | $1K–$15K | 19.9 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-07-22 | 22 days | +7.7% | $1K–$15K 0.1% of NW |
93.8 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-07-22 | 22 days | +7.7% | $1K–$15K 0.1% of NW |
89.5 | ↗ filing |
| Ritchie John Torres | House | SELL ◆ insider convergence | Self | 2025-07-11 | 21 days | +2.3% | $1K–$15K 3.2% of NW 🔥 |
60.0 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-17 | 57 days | +9.6% | $1K–$15K 0.1% of NW |
98.1 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-05-22 | 13 days | +2.6% | $1K–$15K <0.1% of NW |
30.7 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence | Self · JP Morgan Brokerage Account | 2025-05-15 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
49.7 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self · Marjorie IRA | 2025-05-05 | 1 days | -4.5% | $1K–$15K | 59.1 | ↗ filing |
| Julia Letlow | House | BUY ◆ insider divergence · moderate | Self · Merrill Lynch Investment Account #025 | 2025-04-28 | 105 days | +4.2% | $1K–$15K 1.0% of NW |
59.1 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-04-17 | 26 days | +8.7% | $1K–$15K <0.1% of NW |
24.4 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence · moderate | Self · CRT - Standard Unit Trust | 2025-04-17 | 8 days | +7.6% | $50K–$100K <0.1% of NW |
67.4 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
58.7 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2025-04-07 | 23 days | +5.5% | $1K–$15K 0.3% of NW |
49.9 | ↗ filing |
| Dwight Evans | House | SELL ◆ insider convergence · moderate | Self · CETERA | 2025-04-03 | 13 days | -14.1% | $1K–$15K 0.8% of NW |
96.9 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-04-03 | 39 days | -4.9% | $1K–$15K <0.1% of NW |
24.4 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-04-01 | 41 days | -7.0% | $1K–$15K <0.1% of NW |
24.4 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence · moderate | Self | 2025-03-17 | 1 days | -0.3% | $1K–$15K | 64.0 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence · moderate | Self · JP Morgan Brokerage Account | 2025-02-25 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
82.6 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-02-24 | 5 days | +2.4% | $50K–$100K <0.1% of NW |
93.7 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2025-02-05 | 28 days | +10.3% | $1K–$15K | 12.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2025-02-04 | 29 days | +11.4% | $1K–$15K | 13.4 | ↗ filing |
| Julia Letlow | House | SELL ◆ insider convergence · moderate | Self · Merrill Lynch Investment Account #025 | 2025-01-24 | 199 days | +18.7% | $1K–$15K 1.0% of NW |
49.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2025-01-22 | 13 days | +12.3% | $1K–$15K | 14.1 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Child · Morgan Stanley Active Assets (5) | 2025-01-15 | 16 days | +7.3% | $1K–$15K 0.3% of NW |
67.2 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2025-01-15 | 16 days | +7.3% | $1K–$15K 0.3% of NW |
67.2 | ↗ filing |
| Virginia Foxx | House | BUY ◆ insider divergence | Self | 2024-12-06 | 31 days | +2.2% | $1K–$15K 0.2% of NW |
98.1 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-12-06 | 32 days | +1.9% | $1K–$15K | 6.8 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2024-11-20 | 1 days | +2.4% | $1K–$15K | 59.5 | ↗ filing |
| Julia Letlow | House | BUY ◆ insider divergence | Self · Merrill Lynch Investment Account #025 | 2024-10-23 | 292 days | +8.6% | $1K–$15K 1.0% of NW |
92.2 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2024-10-14 | 24 days | +2.7% | $1K–$15K | 29.6 | ↗ filing |
| Ritchie John Torres | House | BUY ◆ insider divergence | Self | 2024-09-26 | 309 days | +4.7% | $1K–$15K 3.2% of NW 🔥 |
94.0 | ↗ filing |
| John James | House | SELL ◆ insider convergence | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -2.1% | $1K–$15K <0.1% of NW |
84.6 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-07-02 | 43 days | — | $1K–$15K 0.1% of NW |
0.3 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence · moderate | Self | 2024-04-10 | 2 days | — | $1K–$15K 0.2% of NW |
5.1 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence · moderate | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-01-23 | 10 days | — | $1K–$15K 0.1% of NW |
6.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-01-10 | 23 days | — | $1K–$15K | 19.6 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence | Self | 2023-12-08 | 4 days | — | $1K–$15K 0.2% of NW |
33.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-12-05 | 30 days | — | $1K–$15K | 33.6 | ↗ filing |
| John James | House | BUY ◆ insider divergence | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
98.8 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-11-08 | 27 days | — | $1K–$15K <0.1% of NW |
32.6 | ↗ filing |
| Greg Stanton | House | SELL | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
59.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2023-10-02 | 35 days | — | $1K–$15K | 50.5 | ↗ filing |
| Robert Wittman | House | SELL ◆ insider convergence | Self · Morgan Stanley INH IRA | 2023-09-28 | 14 days | — | $1K–$15K 0.2% of NW |
31.0 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider divergence | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
93.1 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X141 | 2023-09-08 | 28 days | — | $1K–$15K 0.3% of NW |
50.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Spouse | 2023-09-06 | 29 days | — | $15K–$50K | 83.9 | ↗ filing |
| Lois Frankel | House | BUY ◆ insider divergence | Self · Morgan Stanley IRA - X141 | 2023-09-06 | 30 days | — | $1K–$15K 0.3% of NW |
65.2 | ↗ filing |
| Lois Frankel | House | BUY ◆ insider divergence | Self · Morgan Stanley IRA - X141 | 2023-08-30 | 37 days | — | $1K–$15K 0.3% of NW |
95.6 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence | Spouse | 2023-08-14 | 2 days | — | $15K–$50K 0.7% of NW |
60.1 | ↗ filing |
| Michael Patrick Guest | House | BUY ◆ insider divergence | Spouse · Trust - KF19 | 2023-08-07 | 0 days | — | $1K–$15K | 93.1 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-07-28 | 4 days | — | $1K–$15K | 93.1 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-07-27 | 12 days | — | $1K–$15K <0.1% of NW |
24.8 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence | Self · Daniel Goldman 1997 Trust > DSG Investment Holdings LLC > TACS | 2023-07-14 | 24 days | — | $1K–$15K <0.1% of NW |
19.6 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-07-12 | 27 days | — | $50K–$100K <0.1% of NW |
54.6 | ↗ filing |
| Michael Burgess | House | BUY ◆ insider divergence | Spouse | 2023-07-06 | 0 days | — | $15K–$50K 0.7% of NW |
63.1 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-06-26 | 10 days | — | $1K–$15K <0.1% of NW |
12.3 | ↗ filing |
| Zoe Lofgren | House | SELL BOND ◆ insider convergence | Spouse · John Marshall Collins Rollover IRA | 2023-05-26 | 11 days | — | $1K–$15K 0.1% of NW |
59.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-05-19 | 18 days | — | $1K–$15K <0.1% of NW |
24.8 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence · moderate | Self · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2023-04-28 | 4 days | — | $1K–$15K 0.1% of NW |
48.4 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence · moderate | Spouse · MV Capital - GST Exempt Trust #2 | 2023-04-28 | 4 days | — | $1K–$15K 0.1% of NW |
48.4 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence · moderate | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #2 | 2023-04-28 | 4 days | — | $1K–$15K 0.1% of NW |
48.4 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence · moderate | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-04-10 | 23 days | — | $15K–$50K <0.1% of NW |
60.1 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-03-24 | 13 days | — | $1K–$15K <0.1% of NW |
12.3 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider divergence · moderate | Self · Daniel Goldman 1997 Trust > DSG Investment Holdings LLC > TACS | 2023-03-07 | 27 days | — | $1K–$15K <0.1% of NW |
52.4 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-03-06 | 31 days | — | $1K–$15K <0.1% of NW |
12.3 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-02-21 | 14 days | — | $1K–$15K <0.1% of NW |
4.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-02-07 | 28 days | — | $1K–$15K <0.1% of NW |
5.5 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider divergence · moderate | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-01-31 | 9 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-01-27 | 10 days | — | $1K–$15K <0.1% of NW |
6.8 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-01-20 | 17 days | — | $1K–$15K <0.1% of NW |
8.6 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #3 | 2022-09-12 | 22 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Dwight Evans | House | BUY | Self · PROEQUITIES | 2022-08-05 | 11 days | — | $1K–$15K 0.8% of NW |
99.3 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
31.8 | ↗ filing |
| Kathy Manning | House | SELL | Spouse · MV Capital - GST Exempt Trust #2 | 2022-07-27 | 7 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #3 | 2022-07-15 | 18 days | — | $1K–$15K 0.1% of NW |
59.5 | ↗ filing |
| Robert Wittman | House | BUY | Self · Morgan Stanley INH IRA | 2022-06-16 | 5 days | — | $1K–$15K 0.2% of NW |
26.5 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-03-17 | 25 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| John Rutherford | House | SELL | Self · Westend ETF | 2022-03-16 | 0 days | — | $1K–$15K 0.8% of NW |
40.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-03-08 | 34 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2022-02-18 | 17 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2022-02-09 | 26 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2022-01-28 | 10 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Bob Gibbs | House | BUY | Self | 2021-11-26 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| Zoe Lofgren | House | BUY BOND | Spouse | 2021-08-09 | 31 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Adam Schiff | House | SELL | Self | 2021-07-22 | 1 days | — | $1K–$15K | 99.2 | ↗ filing |
| Marjorie Taylor Greene | House | BUY | Joint | 2021-06-16 | 2 days | — | $1K–$15K | 75.9 | ↗ filing |
| Kathy Manning | House | SELL | Self | 2021-04-30 | 6 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-12-22 | 17 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Joseph Morelle | House | SELL | Joint | 2020-11-20 | 7 days | — | $1K–$15K 1.7% of NW |
84.3 | ↗ filing |
| Richard Allen | House | BUY | Spouse · R.W. Allen & Associates, Inc. > RWA&A - Securities | 2020-11-16 | 19 days | — | $15K–$50K 1.4% of NW |
97.2 | ↗ filing |
| William Timmons | House | SELL | Spouse | 2020-06-29 | 0 days | — | $1K–$15K | 82.9 | ↗ filing |
| Richard Allen | House | BUY | Spouse · R.W. Allen & Associates, Inc. > RWA&A - Securities | 2020-05-12 | 24 days | — | $15K–$50K 1.4% of NW |
99.5 | ↗ filing |
| Robert Wittman | House | BUY | Self | 2020-02-27 | 4 days | — | $1K–$15K 0.2% of NW |
22.3 | ↗ filing |
| Daniel Meuser | House | SELL | Child | 2019-12-11 | 2 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2019-08-14 | 27 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2019-08-13 | 27 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2019-02-04 | 31 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Nicholas Taylor | House | BUY | Spouse | 2019-01-29 | 0 days | — | $1K–$15K | 52.4 | ↗ filing |
| Nicholas Taylor | House | BUY | Spouse | 2019-01-07 | 0 days | — | $1K–$15K | 86.8 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2019-01-04 | 32 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| Gary Palmer | House | SELL | Spouse | 2018-09-18 | 0 days | — | $1K–$15K 0.3% of NW |
84.3 | ↗ filing |
| Gary Palmer | House | BUY | Self | 2018-08-06 | 0 days | — | $1K–$15K 0.3% of NW |
88.5 | ↗ filing |
| Gary Palmer | House | BUY | Joint | 2018-07-12 | 0 days | — | $1K–$15K 0.3% of NW |
94.6 | ↗ filing |
| Robert Wittman | House | SELL | Self | 2018-04-06 | 28 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Debbie Dingell | House | BUY | Spouse | 2018-02-22 | 6 days | — | $1K–$15K 0.1% of NW |
94.6 | ↗ filing |
| Kenneth Buck | House | SELL | Self | 2017-11-07 | 6 days | — | $1K–$15K 3.9% of NW 🔥 |
40.4 | ↗ filing |
| Gary Palmer | House | BUY | Spouse | 2017-11-06 | 0 days | — | $1K–$15K 0.3% of NW |
99.3 | ↗ filing |
| Kenneth Buck | House | BUY | Self | 2017-10-27 | 5 days | — | $1K–$15K 3.9% of NW 🔥 |
86.8 | ↗ filing |
| John Rutherford | House | BUY | Self | 2017-07-17 | 14 days | — | $1K–$15K 0.8% of NW |
75.9 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2016-12-16 | 24 days | — | $15K–$50K 0.2% of NW |
28.8 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2016-09-12 | 3 days | — | $1K–$15K | 40.4 | ↗ filing |
| Debbie Dingell | House | BUY | Spouse | 2016-06-22 | 5 days | — | $1K–$15K 0.1% of NW |
98.8 | ↗ filing |
| Scott Rigell | House | BUY | Spouse | 2016-03-03 | 28 days | — | $15K–$50K | 90.9 | ↗ filing |
| Bill Flores | House | SELL | Self | 2015-12-29 | 7 days | — | $15K–$50K | 56.6 | ↗ filing |
| Robert Wittman | House | BUY | Self | 2015-09-15 | 3 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2015-06-08 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| John Boehner | House | BUY | Self | 2015-03-11 | 0 days | — | $15K–$50K | 90.9 | ↗ filing |
| Bill Flores | House | SELL | Self | 2014-12-16 | 21 days | — | $50K–$100K | 94.3 | ↗ filing |
| Katherine Clark | House | BUY | Self | 2014-11-13 | 7 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Katherine Clark | House | BUY | Self | 2014-10-27 | 24 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2014-10-15 | 36 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Tammy Duckworth | House | SELL | Joint | 2014-09-05 | 5 days | — | $1K–$15K | 40.4 | ↗ filing |
| Pete Sessions | House | SELL | Spouse | 2014-04-23 | 0 days | — | $1K–$15K 0.2% of NW |
98.8 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2014-01-10 | 314 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Tammy Duckworth | House | BUY | Joint | 2013-01-02 | 34 days | — | $1K–$15K | 75.9 | ↗ filing |
| Michael Burgess | House | EXCHANGE | Self | 2013-01-01 | 485 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in ABBV — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
36
Congress trades with insider convergence
35
…with insider divergence
85
Insider open-market trades
Of the congressional trades in ABBV, 36 coincided with corporate insiders moving the same way within 60 days, and 35 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-08-14 | Donoghoe Nicholas | C-suite | SELL | $8.2M | ↗ EDGAR |
| 2026-03-04 | Purdue David Ryan | Other | SELL | $1.2M | ↗ EDGAR |
| 2026-03-02 | Siatis Perry C | Other | SELL 10b5-1 | $1.3M | ↗ EDGAR |
| 2026-03-02 | Siatis Perry C | Other | SELL 10b5-1 | $2.4M | ↗ EDGAR |
| 2026-03-02 | Siatis Perry C | Other | SELL 10b5-1 | $612K | ↗ EDGAR |
| 2026-02-25 | Siatis Perry C | Other | SELL 10b5-1 | $5.1M | ↗ EDGAR |
| 2025-08-12 | SALEKI-GERHARDT AZITA | C-suite | SELL | $8.4M | ↗ EDGAR |
| 2025-08-05 | Donoghoe Nicholas | C-suite | SELL | $641K | ↗ EDGAR |
| 2025-08-05 | Donoghoe Nicholas | C-suite | SELL | $2.0M | ↗ EDGAR |
| 2025-03-31 | Stewart Jeffrey Ryan | C-suite | SELL | $5.4M | ↗ EDGAR |
| 2025-03-31 | Stewart Jeffrey Ryan | C-suite | SELL | $7.0M | ↗ EDGAR |
| 2025-03-14 | Reents Scott T | C-suite | SELL | $3.7M | ↗ EDGAR |
| 2025-03-03 | Siatis Perry C | Other | SELL 10b5-1 | $3.8M | ↗ EDGAR |
| 2025-03-03 | GONZALEZ RICHARD A | Director | SELL | $1.3M | ↗ EDGAR |
| 2025-03-03 | RICHMOND TIMOTHY J. | C-suite | SELL 10b5-1 | $1.2M | ↗ EDGAR |
| 2025-03-03 | RICHMOND TIMOTHY J. | C-suite | SELL 10b5-1 | $3.2M | ↗ EDGAR |
| 2025-03-03 | RICHMOND TIMOTHY J. | C-suite | SELL 10b5-1 | $127K | ↗ EDGAR |
| 2025-02-28 | Siatis Perry C | Other | SELL 10b5-1 | $558K | ↗ EDGAR |
| 2025-02-28 | Siatis Perry C | Other | SELL 10b5-1 | $1.4M | ↗ EDGAR |
| 2025-02-28 | Siatis Perry C | Other | SELL 10b5-1 | $75K | ↗ EDGAR |
| 2025-02-28 | GONZALEZ RICHARD A | Director | SELL | $19.0M | ↗ EDGAR |
| 2025-02-26 | RICHMOND TIMOTHY J. | C-suite | SELL 10b5-1 | $283K | ↗ EDGAR |
| 2025-02-26 | RICHMOND TIMOTHY J. | C-suite | SELL 10b5-1 | $970K | ↗ EDGAR |
| 2025-02-26 | RICHMOND TIMOTHY J. | C-suite | SELL 10b5-1 | $311K | ↗ EDGAR |
| 2025-02-26 | RICHMOND TIMOTHY J. | C-suite | SELL 10b5-1 | $870K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-09-14 | Pete Sessions | SELL | $15K–$50K |
| ◆ insider | 2026-08-14 | Donoghoe Nicholas C-suite | SELL | $8.2M |
| Congress | 2026-05-05 | Josh Gottheimer | SELL | $1K–$15K |
| Congress | 2026-03-30 | Rohit Khanna | SELL | $15K–$50K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $15K–$50K |
| ◆ insider | 2026-03-04 | Purdue David Ryan Other | SELL | $1.2M |
| ◆ insider | 2026-03-02 | Siatis Perry C Other 10b5-1 | SELL | $1.3M |
| ◆ insider | 2026-03-02 | Siatis Perry C Other 10b5-1 | SELL | $2.4M |
| ◆ insider | 2026-03-02 | Siatis Perry C Other 10b5-1 | SELL | $612K |
| ◆ insider | 2026-02-25 | Siatis Perry C Other 10b5-1 | SELL | $5.1M |
| Congress | 2025-12-18 | Julie Johnson | SELL | $1K–$15K |
| Congress | 2025-12-08 | Julia Letlow | SELL | $1K–$15K |
| Congress | 2025-11-13 | Julie Johnson | SELL | $1K–$15K |
| Congress | 2025-10-31 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-08-14 | Julie Johnson | SELL | $1K–$15K |
| ◆ insider | 2025-08-12 | SALEKI-GERHARDT AZITA C-suite | SELL | $8.4M |
| ◆ insider | 2025-08-05 | Donoghoe Nicholas C-suite | SELL | $641K |
| ◆ insider | 2025-08-05 | Donoghoe Nicholas C-suite | SELL | $2.0M |
| Congress | 2025-08-04 | Marjorie Taylor Greene | BUY | $1K–$15K |
| Congress | 2025-07-22 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-07-22 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-07-11 | Ritchie John Torres | SELL | $1K–$15K |
FAQ Common questions
How much has Congress traded ABBV?
73 disclosed buys and 64 sells of ABBV (Abbvie Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade ABBV?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.